 <h1>Dibent Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>dicyclomine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about dicyclomine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Dibent.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to dicyclomine: oral capsules and tablets, oral solution, parenteral injection</i></p><p>Side effects include:</p><p>Most adverse effects are manifestations of pharmacologic effects at muscarinic-cholinergic receptors and usually are reversible when therapy is discontinued. </p><p>Severity and frequency of adverse effects are dose related and individual intolerance varies greatly; although adverse effects occasionally may be obviated by a reduction in dosage, this also will likely eliminate potential therapeutic effects.   If dosage of â‰¥80 mg daily cannnot be achieved because of intolerance, discontinue dicyclomine (the active ingredient contained in Dibent)   </p><p>Dry mouth, dizziness, blurred vision, nausea, light-headedness (especially with the injectable form), drowsiness, weakness, nervousness. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dicyclomine: compounding powder, intramuscular solution, oral capsule, oral syrup, oral tablet</i></p><h3>General</h3><p>-The most serious adverse reactions include cardiovascular and central nervous system symptoms.</p><p>-The most common adverse reactions are dizziness, dry mouth, vision blurred, nausea, somnolence, asthenia and nervousness, fever, tachycardia, agitation, and dry skin/mucous membranes.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (33%), nausea (14%)</p><p><b>Rare</b> (less than 0.1%): Constipation, anorexia</p><p><b>Frequency not reported</b>: Thirst, delayed gastric emptying time, reduced gastric acid secretion, gastroesophageal reflux</p><p><b>Postmarketing reports</b>: Abdominal distension, abdominal pain, dyspepsia, constipation, dry mouth, nausea, vomiting<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (40%)</p><p><b>Common</b> (1% to 10%): Somnolence, nervousness</p><p><b>Rare</b> (less than 0.1%): Sedation, headache</p><p><b>Postmarketing reports</b>: Dizziness, headache, somnolence, syncope<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Blurred vision (27%)</p><p><b>Frequency not reported</b>: Follicular conjunctivitis, all muscarinic antagonists can precipitate glaucoma</p><p><b>Postmarketing reports</b>: Cycloplegia, mydriasis, blurred vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia</p><p><b>Frequency not reported</b>: Fatigue</p><p><b>Postmarketing reports</b>: Malaise, fatigue<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Rash</p><p><b>Postmarketing reports</b>: Allergic dermatitis, erythema, rash<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Dysuria<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Urinary retention, impotence in male patients</p><p><b>Postmarketing reports</b>: Suppressed lactation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Palpitations, tachyarrhythmias, thrombosis, thrombophlebitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Face edema, angioedema, anaphylactic shock<sup>[Ref]</sup></p><h3>Local</h3><p><b>Postmarketing reports</b>: Local pain, edema, skin color change, reflex sympathetic dystrophy syndrome (caused by inadvertent IV injection)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Postmarketing reports</b>: Delirium or symptoms of delirium such as amnesia (or transient global amnesia), nervousness, agitation, confusional state, delusion, disorientation, hallucination (including visual hallucination), and mania, mood (altered and pseudodementia).<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Postmarketing reports</b>: Dyspnea, nasal congestion<sup>[Ref]</sup></p><p id="ref_1">1. Kagan G, Huddlestone L, Wolstencroft P "Comparison of dicyclomine with antacid and without antacid in dyspepsia." J Int Med Res 12 (1984): 174-8</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Bentyl (dicyclomine)." Aventis Pharmaceuticals, Kansas City, MO. </p><h2>More about Dibent (dicyclomine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: anticholinergics/antispasmodics</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Irritable Bowel Syndrome</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>